CASP8 and cancer: It is likely that Casp8 malfunction leads to ICD in cancer cells, which may provoke an adaptive immune response, facilitating CD8+ T cell infiltration and inducing an inflamed (hot) TME, which in turn improves the efficacy of ICB immunotherapies.